Director/PDMR Shareholding
16 September 2026
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that, further to the vesting on 13 September 2026 of conditional nil-cost options granted in 2023 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table A below; and conditional nil-cost options granted in 2023 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table B below, members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 14 September 2026 on the London Stock Exchange, to offset income tax and social security liabilities due on the exercises and retained the following balances of ordinary shares:
|
PDMR Name |
PSP Nil-Cost Options (Table A) |
DSBP (Table B) |
||||
|
Exercised |
Sold to offset taxes due on exercise |
Retained net of tax |
Exercised |
Sold to offset taxes due on exercise |
Retained net of tax |
|
|
Jorgen Kokke |
111,388 |
50,236 |
61,152 |
N/A |
N/A |
N/A |
|
Matt Culbertson |
23,183 |
6,751 |
16,432 |
1,772 |
516 |
1,256 |
|
Elena Rice |
20,308 |
8,684 |
11,624 |
1,459 |
624 |
835 |
|
Angelle Rosata |
18,399 |
7,371 |
11,028 |
1,237 |
496 |
741 |
Conditional nil-cost options granted under the PSP were subject to relevant performance conditions, measured over a three-year performance period which commenced on 1 July 2023 and ended on 30 June 2026. Following assessment of the performance conditions, the Remuneration Committee determined that the proportion of awards to which performance conditions applied would vest at 89.8% of the original grant and the balance of awards have lapsed.
Genus also announces that, further to the vesting on 13 September 2026 of conditional share awards granted in 2023 and 2024 under the Genus 2019 Performance Share Plan (the 'PSP'), as listed in table C below, Mark Birri, member of GELT, sold ordinary shares in Genus on 15 September 2026 on the London Stock Exchange, to offset income tax and social security liabilities due on the releases and retained the following balances of ordinary shares:
|
PDMR Name |
PSP Share Awards (Table C) |
||
|
Released |
Sold to offset taxes due on exercise |
Retained net of tax |
|
|
Mark Birri |
a. 2,246 b. 1,726 |
a. 1,059 b. 814 |
a. 1,187 b. 912 |
Conditional share awards were granted to Mark Birri under the PSP prior to becoming a member of GELT. These conditional share awards were not subject to company performance conditions.
The below notifications, made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, give further detail on the number of nil-cost options exercised and ordinary shares sold on 14 September 2026 and 15 September 2026.
For further information please contact:
Genus:
Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT 2019 Performance Share Plan Exercise
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||||
|
a. |
Name |
1. Jorgen Kokke 2. Matt Culbertson 3. Elena Rice 4. Angelle Rosata
|
|||||||||||
|
2. |
Reason for the notification |
||||||||||||
|
a. |
Position/status |
1. Chief Executive Officer 2. Chief Operating Officer, Genus PIC 3. Chief Scientific Officer 4. Chief Human Resources Officer
|
|||||||||||
|
b. |
Initial notification /Amendment |
Initial notification |
|||||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||||
|
a. |
Name |
Genus plc |
|||||||||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
|||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||||||||
|
b. |
Nature of the transaction |
Exercise of nil-cost options under the PSP. |
|||||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 4 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
|||||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
NA
|
|||||||||||
|
e. |
Date of the transaction |
2026-09-14 |
|||||||||||
|
f. |
Place of the transaction |
Outside a trading venue. |
|||||||||||
|
5. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||||
|
a.
|
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||||||||
|
b. |
Nature of the transaction |
Sale of shares arising from the exercise of nil-cost options under the PSP to offset income tax and social security liabilities due on the exercise. |
|||||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 4 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
|||||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
NA
|
|||||||||||
|
e. |
Date of the transaction |
2026-09-14 |
|||||||||||
|
f. |
Place of the transaction |
London Stock Exchange, Main Market (XLON)
|
|||||||||||
Table B - GELT Deferred Share Bonus Plan Exercise
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||||
|
a. |
Name |
1. Matt Culbertson 2. Elena Rice 3. Angelle Rosata
|
|||||||||
|
2. |
Reason for the notification |
||||||||||
|
a. |
Position/status |
1. Chief Operating Officer, Genus PIC 2. Chief Scientific Officer 3. Chief Human Resources Officer
|
|||||||||
|
b. |
Initial notification /Amendment |
Initial notification |
|||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||||
|
a. |
Name |
Genus plc |
|||||||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
|||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||||||
|
b. |
Nature of the transaction |
Exercise of nil-cost options under the DSBP. |
|||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
|||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
NA
|
|||||||||
|
e. |
Date of the transaction |
2026-09-14 |
|||||||||
|
f. |
Place of the transaction |
Outside a trading venue. |
|||||||||
|
5. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||||
|
a.
|
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||||||
|
b. |
Nature of the transaction |
Sale of shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise. |
|||||||||
|
c. |
Price(s) and volume(s) |
Numbers 1 to 3 in the left-hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.
|
|||||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
NA
|
|||||||||
|
e. |
Date of the transaction |
2026-09-14 |
|||||||||
|
f. |
Place of the transaction |
London Stock Exchange, Main Market (XLON)
|
|||||||||
Table C - GELT 2019 Performance Share Plan Release
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
||||||||
|
a. |
Name |
Mark Birri |
|||||||
|
2. |
Reason for the notification |
||||||||
|
b. |
Position/status |
Chief Corporate Development Officer |
|||||||
|
c. |
Initial notification /Amendment |
Initial notification |
|||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||||
|
d. |
Name |
Genus plc |
|||||||
|
e. |
LEI |
54930022EOITNKSIGH56 |
|||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||
|
f. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||||
|
g. |
Nature of the transaction |
Release of conditional share awards under the PSP. |
|||||||
|
h. |
Price(s) and volume(s) |
|
|||||||
|
i. |
Aggregated information · Aggregated volume · Price
|
NA
|
|||||||
|
j. |
Date of the transaction |
2026-09-15 |
|||||||
|
k. |
Place of the transaction |
Outside a trading venue. |
|||||||
|
5. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||||
|
a.
|
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
|||||||
|
b. |
Nature of the transaction |
Sale of shares arising from the release of conditional share awards under the PSP to offset income tax and social security liabilities due on the release. |
|||||||
|
c. |
Price(s) and volume(s) |
|
|||||||
|
d. |
Aggregated information · Aggregated volume · Price
|
|
|||||||
|
e. |
Date of the transaction |
2026-09-15 |
|||||||
|
f. |
Place of the transaction |
London Stock Exchange, Main Market (XLON)
|
|||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE